OTC and urea cycle disorder: Being known as Buphenyl® or triButyrate® in the US or Ammonaps® in Sweden, it is used as a medication against urea cycle disorders involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase.